Supplemental Annuity Collective Trust (SACT) of New Jersey’s AbbVie ABBV Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85M	Sell	11,332 -635	-5%	-$137K	0.73%	24
2026 Q1	$2.6M	Buy	11,967 +9,005	+304%	+$2M	0.73%	21
2025 Q4	$677K	Sell	2,962 -800	-21%	-$182K	0.17%	127
2025 Q3	$871K	Sell	3,762 -1,800	-32%	-$367K	0.23%	100
2025 Q2	$1.03M	Hold	5,562	–	–	0.29%	86
2025 Q1	$1.17M	Hold	5,562	–	–	0.37%	66
2024 Q4	$988K	Sell	5,562 -2,000	-26%	-$368K	0.29%	83
2024 Q3	$1.49M	Hold	7,562	–	–	0.44%	55
2024 Q2	$1.3M	Sell	7,562 -4,000	-35%	-$663K	0.4%	56
2024 Q1	$2.11M	Hold	11,562	–	–	0.66%	28
2023 Q4	$1.79M	Sell	11,562 -5,500	-32%	-$802K	0.62%	30
2023 Q3	$2.54M	Hold	17,062	–	–	0.96%	17
2023 Q2	$2.3M	Hold	17,062	–	–	0.82%	17
2023 Q1	$2.72M	Hold	17,062	–	–	1.06%	14
2022 Q4	$2.76M	Hold	17,062	–	–	1.14%	13
2022 Q3	$2.29M	Hold	17,062	–	–	1%	15
2022 Q2	$2.61M	Sell	17,062 -2,900	-15%	-$443K	1.04%	14
2022 Q1	$3.24M	Sell	19,962 -2,100	-10%	-$305K	1.06%	12
2021 Q4	$2.99M	Hold	22,062	–	–	0.91%	15
2021 Q3	$2.38M	Hold	22,062	–	–	0.78%	19
2021 Q2	$2.48M	Hold	22,062	–	–	0.81%	19
2021 Q1	$2.39M	Hold	22,062	–	–	0.83%	20
2020 Q4	$2.36M	Hold	22,062	–	–	0.88%	18
2020 Q3	$1.93M	Hold	22,062	–	–	0.81%	24
2020 Q2	$2.17M	Buy	22,062 +6,062	+38%	+$534K	0.99%	17
2020 Q1	$1.22M	Hold	16,000	–	–	0.68%	34
2019 Q4	$1.42M	Hold	16,000	–	–	0.59%	34
2019 Q3	$1.21M	Hold	16,000	–	–	0.55%	37
2019 Q2	$1.16M	Buy	16,000 +1,000	+7%	+$78.6K	0.51%	39
2019 Q1	$1.21M	Hold	15,000	–	–	0.54%	43
2018 Q4	$1.38M	Hold	15,000	–	–	0.71%	30
2018 Q3	$1.42M	Hold	15,000	–	–	0.59%	43
2018 Q2	$1.39M	Hold	15,000	–	–	0.6%	43
2018 Q1	$1.42M	Buy	15,000 +2,000	+15%	+$220K	0.62%	38
2017 Q4	$1.26M	Sell	13,000 -2,000	-13%	-$188K	0.53%	57
2017 Q3	$1.33M	Sell	15,000 -4,849	-24%	-$369K	0.59%	49
2017 Q2	$1.44M	Hold	19,849	–	–	0.65%	39
2017 Q1	$1.29M	Hold	19,849	–	–	0.58%	52
2016 Q4	$1.24M	Hold	19,849	–	–	0.59%	57
2016 Q3	$1.25M	Hold	19,849	–	–	0.62%	49
2016 Q2	$1.23M	Hold	19,849	–	–	0.61%	49
2016 Q1	$1.13M	Hold	19,849	–	–	0.57%	52
2015 Q4	$1.18M	Hold	19,849	–	–	0.6%	48
2015 Q3	$1.08M	Hold	19,849	–	–	0.57%	51
2015 Q2	$1.33M	Hold	19,849	–	–	0.64%	45
2015 Q1	$1.16M	Hold	19,849	–	–	0.55%	55
2014 Q4	$1.3M	Hold	19,849	–	–	0.61%	46
2014 Q3	$1.15M	Hold	19,849	–	–	0.56%	50
2014 Q2	$1.12M	Hold	19,849	–	–	0.54%	51
2014 Q1	$1.02M	Hold	19,849	–	–	0.5%	58
2013 Q4	$1.05M	Hold	19,849	–	–	0.52%	53
2013 Q3	$888K	Hold	19,849	–	–	0.48%	60
2013 Q2	$821K	Buy	+19,849	New	+$868K	0.46%	63

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's ABBV Position: Q2 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its AbbVie (ABBV) stake by 5.3% in Q2 2026, selling an estimated $137K and leaving 11,332 shares worth $2.85M. The position accounts for 0.73% of the portfolio, ranked #24.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.24M in Q1 2022. 3,435 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Supplemental Annuity Collective Trust (SACT) of New Jersey held 11,332 shares of AbbVie worth $2.85M as of Q2 2026.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 635 AbbVie shares in Q2 2026, an estimated $137K.
AbbVie made up 0.73% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #24 holding.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Supplemental Annuity Collective Trust (SACT) of New Jersey's AbbVie position peaked at $3.24M in Q1 2022.
3,435 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.